LUGPA Study Underscores Prostate Cancer Secreening Saves Lives
In a comprehensive study published today in the New England Journal of Medicine, PSA screening was shown to reduce the mortality rate of prostate cancer by 29 percent. The Large Urology Group Practice Association (LUGPA), representing more than 1,800 urologists, stated that today’s study confirmed what urologists and other healthcare providers have known for years—that PSA-based screening is a critical,
…